# Amryt Pharma plc

Amryt Pharma plc is an other based in Dublin, Ireland.

## Overview

- **Organization type:** other
- **Headquarters:** Dublin, Ireland
- **Region:** Europe
- **Address:** Dublin, Ireland
- **Assets under management:** Undisclosed
- **Website:** https://amrytpharma.com
- **LinkedIn:** https://www.linkedin.com/company/amryt-pharma

## Regulatory record

- **Reports private funds:** No

## About

Chiesi Farmaceutici S.p.A. acquired Amryt Pharma on April 12, 2023. Amryt develops and delivers treatments for patients with rare and orphan diseases.

## Sectors

- Biotech & Life Sciences

## Questions

### Who runs investment decisions at Amryt Pharma?

Investment and capital-allocation decisions are overseen by the board of directors and executive management, led by CEO Dr. Joe Wiley. The company does not have a single designated investment committee separate from its corporate governance structure (per public filings).

### How does Amryt Pharma source proprietary deal flow?

Amryt sources drug candidates through internal R&D, in-licensing from academic institutions and biotechnology companies, and acquisitions of distressed or undercapitalized assets. The firm's business development team evaluates preclinical and clinical-stage compounds in the rare disease space (per the firm's annual report).

### Does Amryt Pharma participate in fund commitments or only direct deals?

Amryt Pharma does not act as a fund investor; it engages in direct corporate transactions, including R&D expenditures, licensing agreements, and acquisitions of drug assets or companies. The firm's investment activity is operational rather than allocator-based.

### What investment stages does Amryt Pharma typically target?

As a commercial-stage biopharmaceutical firm, Amryt targets assets across clinical development (Phase 2 and Phase 3) and approved marketed products. The company acquires or licenses compounds that can be integrated into its rare-disease pipeline (per the firm's business strategy disclosures).

### Which sectors does Amryt Pharma explicitly avoid?

Amryt Pharma explicitly focuses on rare disease therapeutics and does not invest in other therapeutic areas such as oncology, central nervous system disorders, or infectious disease, according to its publicly stated strategy.

## Related profiles

- [TDM Partners Limited](https://altss.com/profile/tdm-partners-limited)
- [Ticket City](https://altss.com/profile/ticket-city)

---

Last updated: 2026-07-11T16:13:44.000Z

Canonical page: https://altss.com/profile/amryt-pharma-plc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology